The move marks a significant milestone in the country’s drive toward vaccine sustainability, sovereignty and long-term health security.
To support this transition, the National Vaccine Institute has launched a nationwide Vaccine Perception Survey to assess public trust and acceptance of locally manufactured vaccines.
The two-month survey, running from February 16 to March 10, 2026, is being conducted in 55 districts across all 16 regions. It includes structured interviews with more than 11,000 respondents, alongside focus group discussions in selected districts to gather in-depth community insights.
The study will examine public attitudes toward vaccines, identify drivers of confidence, assess barriers to accepting Made-in-Ghana vaccines, and map misinformation trends. Also to establish a national baseline for vaccine confidence and assess how regulatory approval by the Food and Drugs Authority influences acceptance.
Chief Executive Officer of the National Vaccine Institute, Sodzi Sodzi-Tettey in a statement says the exercise is about listening to communities, not promoting products. He emphasized that as Ghana begins manufacturing its own vaccines, public trust, transparency, and community engagement will be critical to success.
‘‘We urge residents in the selected districts to participate, in the survey. We assure them that their responses will remain confidential. the survey will help ensure that locally produced vaccines are not only scientifically sound, but also widely trusted, reinforcing Ghana’s leadership in immunization across West Africa.’’ He noted.
Officials say the findings will guide targeted communication strategies tailored to regional and demographic differences, as vaccine confidence varies across the country.
